Moderna Inc. surprised investors Wednesday with the news that its chief financial officer has departed the company just two days after taking up the position, following the disclosure of an internal probe into financial reporting at his former employer. Jorge Gomez, who became Moderna’s CFO on Monday, has left the biotech after Dentsply Sirona Inc. XRAY, 4.98% disclosed the probe. Before joining Moderna, Gomez had been CFO of Dentsply since 2019. Mr. Gomez joined Moderna from Dentsply Sirona, Inc. (Nasdaq: XRAY) where he served as Executive Vice President & Chief Financial Officer since August 2019. At Dentsply Sirona, he was responsible for leading the global finance organization, including strategic finance, FP&A, Accounting, Treasury, Tax, Corporate Audit and Investor Relations, and the Information Technology function. In addition, Mr. Gomez was responsible for leading Dentsply Sirona's sustainability and ESG program. Prior to Dentsply Sirona, Mr. Gomez spent 13 years at Cardinal Health. Joining Cardinal Health in 2006, Gomez has served as CFO since 2018. Previously, he held positions at General Motors Corp., including executive and managerial posts in New York, Singapore, Belgium and Brazil. He has deep business experience in the Asia Pacific, European and Latin American regions.